Super excited our IMvigor010 ctDNA paper just came out in Nature!
https://t.co/ufyXJTBx1h
We show that ctDNA testing after surgery can identify bladdercancer patients with residual disease who are likely to benefit from additional adjuvant immunotherapy - groundbreaking work!